PROCEEDINGS VOLUME 8582
SPIE BIOS | 2-7 FEBRUARY 2013
Biophotonics and Immune Responses VIII
Proceedings Volume 8582 is from: Logo
SPIE BIOS
2-7 February 2013
San Francisco, California, United States
Front Matter: Volume 8582
Proc. SPIE 8582, Front Matter: Volume 8582, 858201 (25 February 2013); doi: 10.1117/12.2021430
Immune Responses in PDT
Proc. SPIE 8582, Photodynamic therapy stimulates anti-tumor immune response in mouse models: the role of regulatory Tcells, anti-tumor antibodies, and immune attacks on brain metastases, 858203 (22 February 2013); doi: 10.1117/12.2001902
Proc. SPIE 8582, Topical photodynamic therapy of squamous cell carcinomas in a hairless mouse model, 858204 (25 February 2013); doi: 10.1117/12.2006297
Selective Photothermal Effects
Proc. SPIE 8582, Effects of interstitial laser immunotherapy for the treatment of metastatic cancer, 858207 (22 February 2013); doi: 10.1117/12.2006462
Proc. SPIE 8582, Biological effects of near-infrared lasers on fibroblast cellular differentiation, proliferation and contraction, 858208 (25 February 2013); doi: 10.1117/12.2001432
Proc. SPIE 8582, Monitoring tissue temperature for photothermal cancer therapy based on photoacoustic imaging: a pilot study, 858209 (22 February 2013); doi: 10.1117/12.2001756
Laser-Nanotechnology in Cancer Treatment
Proc. SPIE 8582, Folate receptor-mediated tumor-targeted upconversion nanocomplex for photodynamic therapy triggered by near-infrared light, 85820A (21 February 2013); doi: 10.1117/12.2003246
Proc. SPIE 8582, Combined photothermal therapy and chemotherapy in cancer using HER-2 targeted PLGA nanoparticles, 85820B (21 February 2013); doi: 10.1117/12.2005500
Proc. SPIE 8582, Photothermal effects of immunologically modified carbon nanotubes, 85820C (21 February 2013); doi: 10.1117/12.999961
In vivo Imaging of Immune Activities
Proc. SPIE 8582, In vivo flow cytometry visualizes the effects of tumor resection on metastasis by real-time monitoring of rare circulating cancer cells, 85820F (22 February 2013); doi: 10.1117/12.2003620
Novel Detection Techniques
Proc. SPIE 8582, Quantitative analysis of contrast to noise ratio using a phase contrast x-ray imaging prototype, 85820H (22 February 2013); doi: 10.1117/12.2001525
Proc. SPIE 8582, Objective evaluation of the microscopic image sharpness for diagnostic metaphase chromosomes, 85820I (21 February 2013); doi: 10.1117/12.2001533
Proc. SPIE 8582, A phantom study to characterize the imaging quality of a phase-contrast tomosynthesis prototype, 85820J (21 February 2013); doi: 10.1117/12.2008644
Poster Session
Proc. SPIE 8582, Anti-tumor response with immunologically modified carbon nanotubes and phototherapy , 85820L (21 February 2013); doi: 10.1117/12.999993
Proc. SPIE 8582, Assessments of urine cofilin-1 in patients hospitalized in the intensive care units with acute kidney injury, 85820N (21 February 2013); doi: 10.1117/12.2001000
Proc. SPIE 8582, Sodium nitroprusside induces apoptosis of rabbit chondrocytes, 85820Q (21 February 2013); doi: 10.1117/12.2002294
Proc. SPIE 8582, Using immunoadjuvant agent glycated chitosan to enhance anti-cancer stem like cell immunity induced by HIFU, 85820R (21 February 2013); doi: 10.1117/12.2002722
Proc. SPIE 8582, Inhibitory efficacy of the quantified prunellae spica extract on H22 tumor bearing mice, 85820S (22 February 2013); doi: 10.1117/12.2002844
Proc. SPIE 8582, A bispecific peptide based near-infrared probe for in vivo tumor diagnosis, 85820T (22 February 2013); doi: 10.1117/12.2003242
Proc. SPIE 8582, Preparation and characterization of a drug carrier for hepatocellular carcinoma targeting, 85820U (22 February 2013); doi: 10.1117/12.2003267
Proc. SPIE 8582, Novel 2DG-based harmine derivatives for targeted cancer therapy, 85820V (21 February 2013); doi: 10.1117/12.2003268
Proc. SPIE 8582, Role of macrophages in circulating prostate cancer cells studied by in vivo flow cytometry, 85820W (22 February 2013); doi: 10.1117/12.2003598
Proc. SPIE 8582, HF-LPLI-treated tumor cells induce NO production in macrophage, 85820Y (22 February 2013); doi: 10.1117/12.2006041
Back to Top